SpyGlass Pharma, Inc. SGP

 — 
27.07 (0.58) (2.10%) as of 25 Sep
Market cap
$924.8M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '25 Dec '24 Dec '23
Net Income
(39.87) (29.16) (13.32)
Depreciation & Amortization
0.61 0.27 0.12
Non Cash Items (Other)
4.11 5.53 0.81
Accounts Receivable Change
(0.01) (0.30) (0.09)
Accounts Payable Change
0.55 1.34 0.17
Change in payables and accrued liability
2.57 1.01 0.27
Change in other assets and liabilities
(0.66) (0.71) (0.25)
Operating Cash Flow
(32.70) (22.03) (12.28)
Capital expenditures
(0.79) (1.99) (0.22)
Short Term Investments Change (Net)
(11.00) 24.25 (20.27)
Investing cash flow
(11.79) 22.26 (20.49)
Equity Repurchase (Common, Net)
(1.28) 0.19 0.01
Equity Repurchase (Preffered, Net)
127.05 — 39.76
Other financial activities
(1.18) — —
Financing cash flow
124.59 0.19 39.77
Change in Cash
80.09 0.42 7.01
Beginning Cash
16.27 15.85 8.84
Ending Cash
96.36 16.27 15.85
Stock Based Compensation
2.79 1.49 0.87
Dividends Paid (Common)
0.00 0.00 0.00
Assets Liabilities Change (Total)
2.45 1.34 0.11
Investments Change (Net)
(11.00) 24.25 (20.27)
Issuance/Purchase of Shares
125.77 0.19 39.77
Other line items
Revenue per Employee
0.00 0.00 —

Fold the line items

In millions of $ except per-share values · columns are period end dates